Display options
Cite
Vasina DV, Antonova NP, Vorobev AM, et al. Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by . Antibiotics (Basel). 2021;10(10)doi: 10.3390/antibiotics10101260.
Vasina, D. V., Antonova, N. P., Vorobev, A. M., Laishevtsev, A. I., Kapustin, A. V., Zulkarneev, E. R., Bochkareva, S. S., Kiseleva, I. A., Anurova, M. N., Aleshkin, A. V., Tkachuk, A. P., & Gushchin, V. A. (2021). Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by . Antibiotics (Basel, Switzerland), 10(10), . https://doi.org/10.3390/antibiotics10101260
Vasina, Daria V, et al. "Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by ." Antibiotics (Basel, Switzerland) vol. 10,10 (2021). doi: https://doi.org/10.3390/antibiotics10101260
Vasina DV, Antonova NP, Vorobev AM, Laishevtsev AI, Kapustin AV, Zulkarneev ER, Bochkareva SS, Kiseleva IA, Anurova MN, Aleshkin AV, Tkachuk AP, Gushchin VA. Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by . Antibiotics (Basel). 2021 Oct 16;10(10). doi: 10.3390/antibiotics10101260. PMID: 34680839; PMCID: PMC8532708.
Copy Download .nbib Format: NLM
Share it on

Antibiotics (Basel). 2021 Oct 16;10(10). doi: 10.3390/antibiotics10101260.

Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by .

Antibiotics (Basel, Switzerland)

Daria V Vasina, Nataliia P Antonova, Aleksei M Vorobev, Aleksei I Laishevtsev, Andrei V Kapustin, Eldar R Zulkarneev, Svetlana S Bochkareva, Irina A Kiseleva, Mariia N Anurova, Andrei V Aleshkin, Artem P Tkachuk, Vladimir A Gushchin

Affiliations

  1. N.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098 Moscow, Russia.
  2. G.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia.
  3. Federal State Budget Scientific Institution "Federal Scientific Centre VIEV" (FSC VIEV), 117218 Moscow, Russia.
  4. Department of Pharmaceutical Technology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia.
  5. Department of Virology, Biological Faculty, Lomonosov Moscow State University, 119991 Moscow, Russia.

PMID: 34680839 PMCID: PMC8532708 DOI: 10.3390/antibiotics10101260

Abstract

Abscess formation is a common complication of severe life-threatening infections caused by obligate anaerobes.

Keywords: Fusobacterium necrophorum; anaerobes; animal model; endolysin; enzybiotics; gel formulation; topical treatment

References

  1. Front Immunol. 2018 Oct 16;9:2252 - PubMed
  2. Nat Biotechnol. 2019 Jun;37(6):581-586 - PubMed
  3. J Crit Care Med (Targu Mures). 2017 Nov 8;3(4):141-147 - PubMed
  4. Lett Appl Microbiol. 2014 Oct;59(4):355-61 - PubMed
  5. BMJ Case Rep. 2013 Aug 20;2013: - PubMed
  6. Drug Dev Ind Pharm. 2013 Feb;39(2):382-92 - PubMed
  7. Appl Microbiol Biotechnol. 2014 Mar;98(6):2495-505 - PubMed
  8. Hepatol Res. 2011 Feb;41(2):194-6 - PubMed
  9. Crit Rev Microbiol. 2020 Sep;46(5):548-564 - PubMed
  10. Chem Soc Rev. 2021 Feb 21;50(4):2839-2891 - PubMed
  11. Bacteriol Rev. 1977 Jun;41(2):373-90 - PubMed
  12. Int J Antimicrob Agents. 2020 Feb;55(2):105844 - PubMed
  13. Int J Antimicrob Agents. 2000 Nov;16(3):341-6 - PubMed
  14. Biomolecules. 2020 Mar 12;10(3): - PubMed
  15. Viruses. 2015 Jun 12;7(6):3019-34 - PubMed
  16. Antimicrob Agents Chemother. 2019 Jun 24;63(7): - PubMed
  17. Eur J Clin Microbiol Infect Dis. 2021 Jul;40(7):1461-1470 - PubMed
  18. J Clin Invest. 2020 Jul 1;130(7):3750-3760 - PubMed
  19. J Glob Antimicrob Resist. 2020 Sep;22:32-39 - PubMed
  20. Clin Microbiol Rev. 2001 Apr;14(2):244-69 - PubMed
  21. Front Microbiol. 2019 Jan 09;9:3302 - PubMed
  22. J Infect Chemother. 2016 Jan;22(1):1-13 - PubMed
  23. Thromb Res. 2020 Dec;196:494-499 - PubMed
  24. Chem Soc Rev. 2018 Sep 17;47(18):6917-6929 - PubMed
  25. Int J Pharm. 2015 Dec 30;496(2):219-39 - PubMed
  26. Antimicrob Agents Chemother. 2015 Apr;59(4):1983-91 - PubMed
  27. Am J Respir Crit Care Med. 2011 Oct 15;184(8):957-63 - PubMed
  28. Antimicrob Agents Chemother. 2016 May 23;60(6):3480-8 - PubMed
  29. Antimicrob Agents Chemother. 2016 Apr 22;60(5):2671-9 - PubMed
  30. Nature. 2011 May 12;473(7346):174-80 - PubMed
  31. Am J Med. 1983 Aug;75(2):225-31 - PubMed
  32. Nat Rev Microbiol. 2020 May;18(5):275-285 - PubMed
  33. Int J Pediatr Otorhinolaryngol. 2014 Jan;78(1):10-3 - PubMed
  34. Viruses. 2019 Mar 21;11(3): - PubMed
  35. J Med Microbiol. 2013 Nov;62(Pt 11):1755-1759 - PubMed
  36. Viruses. 2019 Jan 24;11(2): - PubMed

Publication Types